Tri-Heal Max Protocol
Also known as: Tri-Heal Max, THM, Enhanced Wolverine Stack
High-Dose Three-Peptide Healing Blend
Overview
Tri-Heal Max is an enhanced healing peptide blend featuring a higher dose of TB-500 (25mg) combined with BPC-157 (10mg) and KPV (10mg) for a total of 45mg per vial. This formulation emphasizes TB-500's tissue repair and cellular migration properties, complemented by BPC-157's growth factor upregulation and KPV's anti-inflammatory effects. The higher TB-500 ratio (2.5:1:1) compared to standard healing stacks targets more significant tissue damage or accelerated recovery needs.
Key benefits
- Enhanced TB-500 dosing for significant injuries
- Multi-pathway tissue regeneration
- Anti-inflammatory effects from KPV
- Complementary healing mechanisms
- Single injection convenience
- May accelerate recovery from surgery or injury
- Targets both acute and chronic tissue damage
Mechanism of action
Each peptide contributes distinct healing pathways: TB-500 (Thymosin Beta-4) enhances cellular migration, promotes actin polymerization, and supports blood vessel formation for tissue repair; BPC-157 upregulates growth factors (VEGF, EGF), accelerates wound healing, and provides gastrointestinal protection; KPV (alpha-MSH fragment) inhibits the NF-κB inflammatory pathway, reduces pro-inflammatory cytokines, and may improve injection site tolerability. Together, they address inflammation, tissue regeneration, and cellular repair.
Molecular data
- Type
- Fixed-ratio peptide combination
Sequence
TB-500 + BPC-157 + KPV (2.5:1:1 ratio)
Indications
What the research community uses this compound for, with self-reported effectiveness.
Tissue Healing
Post-Surgical Recovery
Sports Medicine
Dosing protocols
Common protocols by delivery method. Adjust the curve below to model accumulation in your own cycle.
Delivery method
| Protocol | Dose | Frequency | Duration |
|---|---|---|---|
| — | 200-300mcg total blend | Once daily | — |
| — | 300-500mcg total blend | Once daily | — |
| — | 500mcg total blend | Once daily for first 2 weeks, then reduce | — |
| — | Per standard dosing | 4-6 weeks on, 2-4 weeks off | — |
Safety
Reported adverse effects, contraindications, and what to monitor on cycle.
Common side effects
- Injection site reactions (KPV may help reduce these)
- Mild fatigue during healing
- Temporary redness at injection site
Rare side effects
- Headache
- Lightheadedness
- Flu-like symptoms
Contraindications
- No clinical trials on this three-peptide combination
- Active cancer (theoretical concern with growth-promoting peptides)
- Pregnancy or breastfeeding
- Active infection at injection site
Monitoring
- Healing progress of target injury
- Injection site reactions
- General recovery and energy levels
- Any unusual symptoms